-
Something wrong with this record ?
Copper ions regulate cytotoxicity of disulfiram to myeloid leukemia cells
J. Navrátilová, P. Jungová, P. Vaňhara, J. Preisler, V. Kanický, J. Šmarda
Language English Country Greece
Document type Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 2006 to 1 year ago
Freely Accessible Science Journals
from 2006
- MeSH
- Acetylcysteine pharmacology MeSH
- Cell Death drug effects MeSH
- Drug Resistance, Neoplasm drug effects MeSH
- Disulfiram pharmacology MeSH
- Enzyme Inhibitors pharmacology MeSH
- Intracellular Space metabolism drug effects MeSH
- Ions MeSH
- Culture Media, Conditioned MeSH
- Humans MeSH
- Copper pharmacology MeSH
- Leukemia, Myeloid pathology MeSH
- Cell Line, Tumor MeSH
- Cell Count MeSH
- Cell Proliferation drug effects MeSH
- Cell Survival drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
White blood cell (WBC) count is considered a prognostic risk factor in acute myeloid leukemia. As density of leukemic cells increases, the cytotoxic activity of certain anticancer drugs, such as vincristine and doxorubicin, progressively decreases. In this study, we investigated the cell density-dependent induction of apoptosis of human acute myeloid leukemia U937 and ML-1 cells by disulfiram (DSF), the dithiocarbamate drug recently proposed for treatment of human cancers. This effect is dependent on uptake of extracellular copper and its intracellular accumulation. High-density cells cannot uptake and accumulate this metal to a sufficient level that would allow induction of apoptosis due to progressive decrease of its extracellular concentration. Simple addition of copper can resume sensitivity of high-density leukemic cells to DSF and improve efficiency of anti-leukemic therapies using this drug, thus providing benefit to patients with high WBC count.
- 000
- 02716naa 2200457 a 4500
- 001
- bmc11022262
- 003
- CZ-PrNML
- 005
- 20121203113711.0
- 008
- 110729s2009 gr e Eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 0_
- $a Navrátilová, Jarmila $7 xx0160866
- 245 10
- $a Copper ions regulate cytotoxicity of disulfiram to myeloid leukemia cells / $c J. Navrátilová, P. Jungová, P. Vaňhara, J. Preisler, V. Kanický, J. Šmarda
- 314 __
- $a Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 520 9_
- $a White blood cell (WBC) count is considered a prognostic risk factor in acute myeloid leukemia. As density of leukemic cells increases, the cytotoxic activity of certain anticancer drugs, such as vincristine and doxorubicin, progressively decreases. In this study, we investigated the cell density-dependent induction of apoptosis of human acute myeloid leukemia U937 and ML-1 cells by disulfiram (DSF), the dithiocarbamate drug recently proposed for treatment of human cancers. This effect is dependent on uptake of extracellular copper and its intracellular accumulation. High-density cells cannot uptake and accumulate this metal to a sufficient level that would allow induction of apoptosis due to progressive decrease of its extracellular concentration. Simple addition of copper can resume sensitivity of high-density leukemic cells to DSF and improve efficiency of anti-leukemic therapies using this drug, thus providing benefit to patients with high WBC count.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a acetylcystein $x farmakologie $7 D000111
- 650 _2
- $a počet buněk $7 D002452
- 650 _2
- $a buněčná smrt $x účinky léků $7 D016923
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a měď $x farmakologie $7 D003300
- 650 _2
- $a kultivační média speciální $7 D017077
- 650 _2
- $a disulfiram $x farmakologie $7 D004221
- 650 _2
- $a chemorezistence $x účinky léků $7 D019008
- 650 _2
- $a inhibitory enzymů $x farmakologie $7 D004791
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a intracelulární prostor $x metabolismus $x účinky léků $7 D042541
- 650 _2
- $a ionty $7 D007477
- 650 _2
- $a myeloidní leukemie $x patologie $7 D007951
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1#
- $a Foltynová, Pavla. $7 xx0302383
- 700 1_
- $a Vaňhara, Petr, $d 1980- $7 xx0106079
- 700 1_
- $a Preisler, Jan $7 xx0103453
- 700 1#
- $a Kanický, Viktor. $7 _AN053393
- 700 1_
- $a Šmarda, Jan, $d 1961- $7 mzk2006343362
- 773 0_
- $t International Journal of Molecular Medicine $w MED00173213 $g Roč. 24, č. 5 (2009), s. 661-670
- 910 __
- $a ABA008 $b x $y 2
- 990 __
- $a 20110801121354 $b ABA008
- 991 __
- $a 20121203113742 $b ABA008
- 999 __
- $a ok $b bmc $g 881678 $s 732180
- BAS __
- $a 3
- BMC __
- $a 2009 $x MED00173213 $b 24 $c 5 $d 661-670 $m International Journal of Molecular Medicine $n Int. J. Mol. Med.
- LZP __
- $a 2011-4B09/jvme